B
Brian Conway
Researcher at University of British Columbia
Publications - 32
Citations - 2573
Brian Conway is an academic researcher from University of British Columbia. The author has contributed to research in topics: Hepatitis C & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 16, co-authored 32 publications receiving 2531 citations. Previous affiliations of Brian Conway include Vancouver Coastal Health.
Papers
More filters
Journal ArticleDOI
Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel
Martin S. Hirsch,Françoise Brun-Vézinet,Richard T. D'Aquila,Scott M. Hammer,Victoria A. Johnson,Daniel R. Kuritzkes,Clive Loveday,John W. Mellors,Bonaventura Clotet,Brian Conway,Lisa M. Demeter,Stefano Vella,Donna M. Jacobsen,Douglas D. Richman +13 more
TL;DR: The International AIDS Society-USA 13-member physician panel with expertise in basic science, clinical research, and patient care involving HIV resistance to antiretroviral drugs was reconvened to provide recommendations for the clinical use of drug resistance testing as discussed by the authors.
Journal ArticleDOI
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Martin S. Hirsch,Françoise Brun-Vézinet,Bonaventura Clotet,Brian Conway,Daniel R. Kuritzkes,Richard T. D'Aquila,Lisa M. Demeter,Scott M. Hammer,Victoria A. Johnson,Clive Loveday,John W. Mellors,Donna M. Jacobsen,Douglas D. Richman +12 more
TL;DR: The International AIDS Society-USA convened a panel of physicians and scientists with expertise in antiretroviral drug management, HIV-1 drug resistance, and patient care to provide updated recommendations for HIV- 1 resistance testing.
Journal ArticleDOI
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.
Bluma G. Brenner,Jean-Pierre Routy,Marco Petrella,Daniela Moisi,Maureen Oliveira,Mervi Detorio,Bonnie Spira,Vidal Essabag,Brian Conway,Richard G. Lalonde,Rafick-Pierre Sekaly,Mark A. Wainberg +11 more
TL;DR: Results indicate that MDR viruses that are generated following PHI can establish persistent infections as dominant quasispecies despite their impaired replicative competence.
Journal ArticleDOI
Hepatitis C virus reinfection in injection drug users.
TL;DR: Individuals with clearance of HCV infection may have a lower risk of acquiring HCV than individuals who have never been infected, despite ongoing exposure to HCV.
Journal ArticleDOI
A phase II dose‐escalating trial of clevudine in patients with chronic hepatitis B
Patrick Marcellin,Herve Mommeja-Marin,Stephen L. Sacks,George K. K. Lau,Daniel Sereni,Jean-Pierre Bronowicki,Brian Conway,Christian Trepo,M. Robert Blum,Byung Chul Yoo,Elsa Mondou,Jeff Sorbel,Andrea Snow,Franck Rousseau,Hyo-Suk Lee +14 more
TL;DR: Clevudine was well tolerated, with no dose‐limiting toxicities, and increases in alanine aminotransferase was observed in six patients in the 100‐mg cohort, without signs of liver failure, which were associated with improved viral suppression.